LiveRamp bolsters proxy with detailed financials and discloses merger lawsuits ahead of critical vote
RAMP sits 74% above its 52-week low of $21.71 on light trading volume (0.3× avg).
Summary
Facing three merger lawsuits, LiveRamp has voluntarily added detailed financial disclosures to its proxy, including Evercore's valuation work and management retention discussions, ahead of the August 17 shareholder vote on the $2.2B Publicis acquisition.
Key Events · M&A and Partnerships · RAMP
-
Three Merger Lawsuits Filed
Putative stockholders filed suits in California and New York alleging the Definitive Proxy Statement contains materially false or misleading statements about the Merger's economics, process, and conflicts of interest.
-
Supplemental Proxy Disclosures Added
To address litigation and bolster transparency, LiveRamp voluntarily added detailed Evercore financial analyses — including DCF, selected companies, selected transactions, and analyst price targets — along with management employment agreement discussions and the December and LiveRamp Projections to the proxy.
-
Evercore's Valuation Range: $22.32–$49.38
The supplemental disclosures show Evercore's DCF implied $33.83–$49.38 per share, selected companies analysis implied $22.32–$46.21, and selected transactions implied $32.23–$46.06, all compared to the $38.50 merger consideration.
-
Management Retention Talks Detailed
The filing reveals Publicis sought employment commitments from senior LiveRamp management, with CEO Scott Howe signing an employment agreement contingent on the merger closing; other agreements were not finalized at signing.
Analysis · RAMP · Technology
Three stockholder lawsuits allege the proxy omitted key details on deal economics and conflicts. While LiveRamp denies the claims, it is supplementing the proxy with granular Evercore analyses, management employment talks, and updated projections — a defensive move to secure the $38.50/share vote on August 17.
At the time of this filing, RAMP was trading at $37.81 on NYSE in the Technology sector, with a market capitalization of approximately $2.3B. The 52-week trading range was $21.71 to $38.23. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.